Repare Therapeutics Inc (RPTX) — Cash Flow Quality Index
Latest as of September 2025:
0.81x
Repare Therapeutics Inc (RPTX) has a Cash Flow Quality Index of 0.81x as of September 2025. Operating cash flow of $2.65 Million is below net income of $3.26 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RPTX long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
0.81x
Operating CF / Net Income
Operating Cash Flow
$2.65 Million
USD
Net Income
$3.26 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for Repare Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Repare Therapeutics Inc. For live market cap and the full company financial profile, see market value of Repare Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.